Updates and Evolving Treatment Strategies in Acute Myeloid Leukemia

Program Description

Despite advances in therapies for patients with acute myeloid leukemia, the cure rate remains low, with just 5% to 15% of patients aged older than 60 years achieving cure. However, advancements in induction regimens as well as evolving maintenance therapy options have improved outcomes for this patient population. Despite the evolving landscape of AML therapy, older patients with AML undergoing treatment require additional considerations, and pharmacist-led efforts can assist in overcoming these challenges. This activity will examine clinical data for different combination therapies in the treatment landscape of AML, with analysis of cost-efficacy and medication access considerations. The role of managed care pharmacists in implementing clinical pathways and developing evidence-based treatment protocols for the management of older patients with AML to optimize utilization of resources for both patients and the healthcare system will also be examined. 

Target audience: Managed care pharmacists, oncology pharmacists

Type of activity: Application

Release date: August 1, 2022

Expiration date: August 1, 2023

Time to complete activity: 2.0 hours

Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Explore the clinical data for alternative induction regimens in older patients with acute myeloid leukemia (AML).
• Identify the challenges and recent advances in maintenance therapy for older patients with AML.
• Illustrate the managed care considerations in developing treatment pathways that address the unique needs of older patients with AML.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.20 CEU) under the ACPE universal activity number 0290-0000-22-339-H01-P. The activity is available for CE credit through August 1, 2023.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Alison P. Duffy, PharmD BCOP, has the following financial relationship with a commercial interest to disclose:
Speakers Bureau: Amgen

The following contributors have no relevant financial relationships with commercial interests to disclose:

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Amy Seung, PharmD, BCOP, FHOPA; Amy L. Morris, PharmD; Kylie Ferrentino; Abigail Dill; Susan Pordon; Brianna Winters; and Chloe Taccetta.

Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms